Physician profile
Paul Bednarz
NPI 1760476337
$8,643.16
in general payments reported to CMS, 2019-2025
11 companies · $1,687 in 2025
The $1,687 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,536 · 2021: $611 · 2022: $1,268 · 2023: $30.43 · 2024: $1,511 · 2025: $1,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,732 · Food and Beverage: $1,497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,731.60 |
| Food and Beverage | $1,497.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,259.82 | 2019-2025 | |
| Pylant Medical | $1,946.49 | 2019-2025 | |
| Stryker Corporation | $1,030.60 | 2021-2025 | Augment Injectable, Infinity Adaptis, Dart-Fire |
| Wright Medical Technology, INC. | $122.49 | 2019 | |
| Amgen INC. | $75.97 | 2024 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $49.70 | 2024 | Exparel, Iovera, Zilretta |
| Smith+Nephew, INC. | $46.34 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Footprint |
| Bioventus LLC | $33.19 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $32.47 | 2024 | Physio-Stim |
| Depuy Synthes Sales INC. | $30.25 | 2025 | Na, Motoband |
| Horizon Therapeutics Plc | $15.84 | 2023 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Bednarz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.